CSPAN Key Capitol Hill Hearings March 4, 2014
Encouraging minority participation in Clinical Trials is if the researchers themselves represent the diversity of our country. You can see that over and over again. This is a strong reason why we need to focus on improving and expanding our own work force. We have a number of new programs that are quite bold. This is a high personal priority for me, to try to see if we could do a better job of recruiting and retaining and mentoring it and supporting individuals from underrepresented groups in order to populate those Clinical Trial work forces with people who represent our country and would the...